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To the Editor: We read with interest the article by 
Furuya-Kanamori et al. on the proportion of influenza vi-
rus infections that are asymptomatic or subclinical (1), and 
we are troubled by a series of fundamental flaws and er-
rors. We were concerned that the authors presented pooled 
estimates of the asymptomatic fraction, given the massive 
heterogeneity in estimates (Ι2 values of 97%–98% in Table 
1). It is not considered good practice to present pooled es-
timates in instances of massive heterogeneity (2). We were 
very surprised that the authors included volunteer challenge 
studies because it is well known that the severity of these 
infections can be modulated by the route of administration 
and possibly the infectious dose. We also were surprised 
that human infections with avian influenza viruses were in-
cluded because the epidemiology of these infections differs 
markedly from that of human influenza viruses. These stud-
ies were mistakenly labeled as studies of pandemic influen-
za in online Technical Appendix 1 Table 1 (https://wwwnc.
cdc.gov/EID/article/22/6/15-1080-Techapp1.pdf). When 
reviewing serologic studies, the authors did not define a 
specific antibody titer threshold but relied on the choices 
made in individual studies; studies that inferred influenza 
virus infections based on low postepidemic hemagglutina-
tion-inhibition titers, such as 10 or 20, may lack specificity 
because some persons could have preexisting antibodies 
(3). Measurement error can also be a concern. The authors 
probably should have excluded such studies.
In another systematic review of the asymptomatic frac-
tion of influenza virus infections (4), we found that study de-
signs could explain a great deal of heterogeneity in the asymp-
tomatic fraction in studies such as outbreak investigations 
that used molecular testing to confirm influenza virus infec-
tions rather than serologic studies that used antibody titer 
measurements to indicate infections. Asymptomatic frac-
tions were higher in general, and much more heterogeneous, 
in studies that followed the latter approach.
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